Hepatitis B virus directly promotes collagen I expression of LX-2 cells without infection in vitro

Hepatology Research

Volumn 42, Issue 9, 2012, Pages 911-921

  Wu, Xiaoning ^a   Wang, Yu ^a   Cui, Yan ^a   Bai, Qixuan ^a   Ze, Xingyu ^a   Liu, Tianhui ^a   Cong, Min ^a   Wang, Ping ^a   Li, Xinmin ^a   Yin, Gang ^b   Ou, Xiaojuan ^a   You, Hong ^a   Jia, Jidong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b LANZHOU GENERAL HOSPITAL   (China)

Author keywords

Collagen type I; Hepatitis B virus; Human hepatic stellate cell

Indexed keywords

COLLAGEN TYPE 1; HEPATITIS B ANTIBODY; IMMUNOGLOBULIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUPERNATANT; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS PURIFICATION;

EID: 84865133335     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.01000.x     Document Type: Article

References (28)

1. Iloeje UH, Yang HI, Su J etal. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006; 130: 678-86.
2. Dienstag JL, Goldin RD, Heathcote EJ etal. Histological outcome during long-term lamivudine therapy. Gastroenterology 2003; 124: 105-17.
3. Yuen MF, Seto WK, Chow DH etal. Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease. Antivir Ther 2007; 12: 1295-303.
4. Lai M, Hyatt BJ, Nasser I etal. The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol 2007; 47: 760-67.
5. Kumar M, Sarin SK, Hissar S etal. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 2008; 134: 1376-84.
6. Ha MH, Rao HY, Liu F etal. Increased expression of Collagen type? And collagen type? II induced by HBV in hepatic stellate cells. Shi Jie Hua Ren Xiao Hua Za Zhi 2008; 16: 2031-35.
7. Cui Y, Wang Y, Jia JD. HBV infect hepatic stellate cells and affect their proliferation and expression of extracellalar matrix. Hepatology 2007(sup); 46: 877A.
8. Liu X, Zhu ST, You H etal. Hepatitis B virus infects hepatic stellate cells and affects their proliferation and expression of collagen type? Chin Med J (Engl) 2009; 122: 1455-61.
9. Kimura T, Ohno N, Terada N etal. Hepatitis B virus DNA-negative dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domain. J Biol Chem 2005; 280: 21713-19.
10. Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual. Woodbury, NY: Cold Spring Harbor Laboratory Press, 2001.
11. Kaito M, Ohba H, Chiba J etal. The ultrastructural morphology of native hepatitis B virus. Med Mol Morphol 2006; 39: 136-45.
12. Inagaki Y, Okazaki I. Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut 2007; 56: 284-92.
13. Pinzani M. PDGF and signal transduction in hepatic stellate cells. Front Biosci 2002; 7: d1720-6.
14. Borkham-Kamphorst E, van Roeyen CR, Ostendorf T etal. Pro-fibrogenic potential of PDGF-D in liver fibrosis. J Hepatol 2007; 46: 1064-74.
15. Pinzani M, Marra F. Cytokine receptors and signaling in hepatic stellate cells. Semin Liver Dis 2001; 21: 397-416.
16. Lechuga CG, Hernández-Nazara ZH, Hernández E etal. PI3K is involved in PDGF-beta receptor upregulation post-PDGF-BB treatment in mouse HSC. Am J Physiol Gastrointest Liver Physiol 2006; 291: G1051-61.
17. Cao Q, Mak KM, Lieber CS. DLPC decreases TGF-beta1-induced collagen mRNA by inhibiting p38 MAPK in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2002; 283: G1051-61.
18. Molen RG, Sprengers D, Binda RS etal. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 2004; 40: 738-46.
19. Arima S, Akbar SM, Michitaka K etal. Impaired function of antigen-presenting dendritic cells in patients with chronic hepatitis B: localization of HBV DNA and HBV RNA in blood DC by in situ hybridization. Int J Mol Med 2003; 11: 169-74.
20. Shi L, Yue YF, Zhang SL etal. Peripheral blood mononuclear of neonates infected with hepatitis B virus. Zhonghua Er Ke Za Zhi 2006; 44: 855-58.
21. Kock J, Theilmann L, Galle P etal. Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus. Hepatology 1996; 23: 405-13.
22. Untergasser A, Zedler U, Langenkamp A etal. Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection. Hepatology 2006; 43: 539-47.
23. Congly SE, Burak KW, Coffin CS. Hepatitis B immunoglobulin for prevention of hepatitis B virus infection and recurrence after liver transplantation. Expert Rev Clin Immunol 2011; 7: 429-36.
24. Zhang X, Lin SM, Chen TY etal. Asialoglycoprotein receptor interacts with the preS1 domain of hepatitis B virus in vivo and in vitro. Arch Virol 2011; 156: 637-45.
25. Leask A, Abraham D. TGF-β signaling and the fibrotic response. FASEB J. 2004; 18: 816-27.
26. Zhande R, Zhang W, Zheng Y etal. Dephosphorylation by default, a potential mechanism for regulation of insulin receptor substrate-1/2, Akt, and ERK1/2. J Biol Chem 2006; 281: 39071-80.
27. Leivonen SK, Chantry A, Hakkinen L etal. Smad3 mediates transforming growth factor-betainduced collagenase-3 (matrix metalloproteinase-13) expression in human gingival fibroblasts. Evidence for cross-talk between Smad3 and p38 signaling pathways. J Biol Chem 2002; 277: 46338-46.
28. Tsukada S, Westwick JK, Ikejima K etal. SMAD and p38 MAPK signaling pathways independently regulate alpha1(I) collagen gene expression in unstimulated and transforming growth factor-beta-stimulated hepatic stellate cells. J Biol Chem 2005; 280: 10055-64.